Investment Thesis with Kali Norman Elaine Stead's Investment Thesis
Recorded as Principal, Main Sequence
Elaine Stead is a Partner at Main Sequence, the Australian deep tech venture capital firm, where she leads investment in its Humanity Scale Healthcare challenge.
She trained as a scientist, completing a PhD in biochemistry with a focus on stem cell biology at the University of Adelaide, before moving to the commercial side of research. She founded Blue Sky VC, Human VC and Tribe Global Ventures, and was Director of New Ventures and Entrepreneurship at the Australian National University. Across her career she has backed more than 80 startups in Australia, the United States and South-East Asia.
On Day One she has discussed bravery and diversity in investing on First Cheque, and set out her investment thesis on Investment Thesis with Kali Norman.
2 episodes
Start hereElaine Stead's Investment ThesisShe sets out how she invests in healthcare at Main Sequence; the First Cheque episode is a broader talk on bravery and diversity in investing.
Investment Thesis with Kali Norman Recorded as Principal, Main Sequence
First Cheque with Cheryl Mack & Maxine Minter Recorded as Investor
“Bravery is being fearful of something, but doing it anyway. It's not about not being fearful.”
Partner · Main Sequence
Director of New Ventures and Entrepreneurship · Australian National University (ANU)
Founder · Tribe Global Ventures
Founder · Human VC
Founder / Head of Venture Capital · Blue Sky VC
Sources: mseq.vc
Main Sequence is an Australian venture capital firm that invests in deep tech companies, including those built on public research.
4 people · 10 episodes
Spot something wrong? Suggest a correctionUpdated 29 October 2026
Put your brand alongside the voices founders, investors and operators come to hear.
Explore sponsorshipW2D1 Media — the team behind the Day One Network, which helped build Blackbird Ventures' Wild Hearts — builds and produces podcasts for funds, founders and operators. If you want a show built around your brand, let's talk.